Skip to main content

Table 4 The age-standardized incidence and mortality rates along with the ASR -based mortality-to-incidence ratio due to leukemia among males of selected countries (n = 56)

From: Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020

Country

Incidence

Mortality

ASR-based MIR

ASIR

Cum.Risk

ASMR

Cum.Risk

2012

2020

\(\delta\) MIR

Argentina

7.1

1.61

4.8

1.33

0.78

0.68

0.10

Australia

13.2

3.1

4.3

1.75

0.55

0.32

0.23

Austria

9.4

2.15

4.3

1.58

0.38

0.46

-0.08

Belarus

9

1.87

5

1.38

0.61

0.55

0.06

Belgium

13.6

2.92

4.7

1.83

0.45

0.34

0.11

Brazil

5.6

1.3

3.9

1.08

0.75

0.70

0.05

Bulgaria

5.9

0.97

4.9

1.26

0.65

0.83

-0.18

Canada

12.2

2.89

4.3

1.67

0.38

0.35

0.03

Chile

6.6

1.38

4

1.12

0.67

0.61

0.06

Colombia

7.1

1.37

4.8

1.1

0.69

0.68

0.01

Costa Rica

7.3

1.34

4.2

1.11

0.73

0.57

0.16

Croatia

8.3

2.15

5.6

2.11

0.49

0.67

-0.18

Cuba

6

1.13

3.8

0.93

0.69

0.63

0.06

Cyprus

9.5

2.26

7

2.7

0.45

0.74

-0.29

Czechia

9.4

2.28

4.5

1.62

0.50

0.48

0.02

Denmark

10.1

2.39

4.4

1.77

0.45

0.43

0.02

Ecuador

7.5

1.5

5.3

1.26

0.75

0.71

0.04

Egypt

6.3

1.03

5

1.04

0.78

0.79

-0.01

Estonia

11.2

2.35

5.4

2.12

0.57

0.48

0.09

Finland

8.4

1.82

3

1.2

0.39

0.36

0.03

France

11.1

2.69

4.9

1.89

0.41

0.44

-0.03

Germany

9.8

2.26

4.4

1.79

0.23

0.45

-0.22

Iceland

7.9

2.09

3.1

1.56

0.34

0.39

-0.05

Ireland

9.6

2.36

3.6

1.43

0.33

0.37

-0.04

Italy

9.2

1.91

4.4

1.52

0.28

0.48

-0.20

Jamaica

5.1

0.96

3.9

0.79

0.70

0.76

-0.06

Japan

6.8

1.24

3.1

1.03

0.35

0.45

-0.10

Kuwait

6.6

1.62

3.9

1.23

0.63

0.59

0.04

Latvia

9.1

1.89

5.5

1.6

0.64

0.60

0.04

Lithuania

11.7

2.74

5.3

1.58

0.66

0.45

0.21

Luxembourg

9.2

3.37

4

1.92

0.45

0.43

0.02

Malaysia

7

0.82

4.9

0.71

0.80

0.70

0.10

Malta

5.5

1.34

2.3

0.98

0.41

0.42

-0.01

Mauritius

7.3

1.62

4.1

0.93

0.62

0.56

0.06

Netherlands

9.5

2

4.3

1.85

0.37

0.45

-0.08

New Zealand

10.2

2.32

5.2

1.88

0.47

0.51

-0.04

Norway

10.4

2.27

3.9

1.5

0.40

0.37

0.03

Philippines

6.5

1.37

5

1.15

0.68

0.77

-0.09

Poland

8.4

1.81

5

1.75

0.60

0.59

0.01

Portugal

8.8

2.11

4.3

1.53

0.43

0.49

-0.06

Qatar

5.6

0.82

3.7

0.67

0.74

0.66

0.08

Russian Federation

7.9

1.44

4.2

1.02

0.62

0.53

0.09

Serbia

9.5

1.8

5.1

1.4

0.69

0.54

0.15

Singapore

9.9

1.92

3.9

1.23

0.42

0.39

0.03

Slovakia

10.7

2.4

5.9

1.67

0.56

0.55

0.01

Slovenia

8.9

2.69

5.5

2.41

0.48

0.62

-0.14

South Africa

4.6

1.16

3.6

1

0.86

0.78

0.08

Spain

8.2

1.89

3.8

1.34

0.33

0.46

-0.13

Sweden

9

1.89

3.6

1.37

0.35

0.40

-0.05

Switzerland

9.2

2.14

3.7

1.47

0.31

0.40

-0.09

Thailand

6.1

1.01

3.9

0.79

0.61

0.64

-0.03

Trinidad and Tobago

6.2

0.99

3.9

0.93

0.75

0.63

0.12

Ukraine

7.6

1.21

4.2

0.78

0.60

0.55

0.05

United Kingdom

10.6

2.61

3.7

1.51

0.44

0.35

0.09

United States of America

13.4

3.15

4.1

1.6

0.56

0.30

0.26

Uruguay

7.8

1.88

4.4

1.61

0.74

0.56

0.18

  1. ASIR age-standardized incidence rate, Cum cumulative, ASMR age-standardized mortality rate, MIR mortality-to-incidence ratio